KLRB1 and psoriasis: 76.5% of IL17A+ T-cells, 61.4% of IL17F+ T-cells, and 100% of IL17A+IL17F+ T-cells were within the CD161+ T-cell cluster in pretreatment psoriasis lesional skin.